Hannah Johnson - Concepedia

Author

Hannah Johnson

Nuffield Orthopaedic Centre ORCID

Also Known As

H Johnson, H L Johnson, H. Johnson, H.L. Johnson, Hannah Johnson

Publications

376

Citations

H-Index

Concepts

All Affiliations

Nuffield Orthopaedic Centre University of Oxford Institute of Cancer Research

About

Hannah Johnson is an author at Nuffield Orthopaedic Centre specializing in medicine, psychiatry, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	108
2	Education	1	1	28
3	Public Health	1	1	66
4	Child Development	1	1	28
5	Pathology	1	1	14

Hannah Johnson

Publications

360

Citations

H-Index

Page 1

	Year	Citations
The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia Charlotte Brierley, Julie Staves, Corran Roberts, Transfusion	2019	102
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Craig M. McDonald, Eduardo Marbán, Suzanne Hendrix, The Lancet	2022	78
Some factors affecting the fetal heart rate Louis M. Hellman, Hannah Johnson, Walter E. Tolles, American Journal of Obstetrics and Gynecology PhysiologyFetal MedicinePregnancyMaternal HealthMaternal-fetal Medicine	1961	66
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010) Alistair Ring, Lucy Kilburn, Alex Pearson, Clinical Cancer Research	2023	30
<i>ESR1</i> F404 Mutations and Acquired Resistance to Fulvestrant in <i>ESR1</i> -Mutant Breast Cancer Belinda Kingston, Alex Pearson, María Teresa Herrera-Abreu, Cancer Discovery	2023	30
Prenatal methadone exposure: effects on behavior in early infancy. Hannah Johnson, Tal Rosen PubMed Substance UseEducationObject Permanence ScalesEarly InfancyPsychology	1982	28
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial) David Barnes, Peter H. Dutton, Øyvind S. Bruland, BMC Cancer Liposomal Mtp-peEurosarc-memos TrialMalignant DiseaseMedicinePathology	2022	14
Development and Implementation of a Community Paramedicine Program in Rural United States Lucas A. Myers, Peter N. Carlson, Paul Krantz, Western Journal of Emergency Medicine	2020	12

Page 1